Adaptive Biotechnologies Corporation Common Stock ADPT
i
Market dataready · fetched 2026-11-13T17:10:32.608Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T17:10:00.876806822Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T17:10:30.880982+00:00
Adaptive Biotechnologies Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 37.95 | 88.9% | 37.6% | |||
| 35Δ | 35.76 | 87.5% | 31.3% | |||
| 40Δ | 33.89 | 83.6% | 25.8% | |||
| 45Δ | 32.19 | 78.4% | 20.9% | |||
| 50Δ | 30.49 | 73.2% | 16.0% | 30.30 | 70.4% | 9.2% |
| 55Δ | 29.19 | 72.7% | 13.3% | 31.48 | 69.8% | 7.8% |
| 60Δ | 28.04 | 74.2% | 11.6% | 32.66 | 69.2% | 6.5% |
| 65Δ | 26.90 | 75.7% | 9.8% | 33.84 | 68.6% | 5.2% |
| 70Δ | 25.75 | 77.1% | 8.1% | |||
| 75Δ | 24.44 | 80.4% | 6.5% | |||
| 80Δ | 22.81 | 87.1% | 5.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 37.95
- IV
- 88.9%
- B/E move
- 37.6%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 35.76
- IV
- 87.5%
- B/E move
- 31.3%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 33.89
- IV
- 83.6%
- B/E move
- 25.8%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 32.19
- IV
- 78.4%
- B/E move
- 20.9%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 30.49
- IV
- 73.2%
- B/E move
- 16.0%
- Pseudo strike
- 30.30
- IV
- 70.4%
- B/E move
- 9.2%
55Δ
- Pseudo strike
- 29.19
- IV
- 72.7%
- B/E move
- 13.3%
- Pseudo strike
- 31.48
- IV
- 69.8%
- B/E move
- 7.8%
60Δ
- Pseudo strike
- 28.04
- IV
- 74.2%
- B/E move
- 11.6%
- Pseudo strike
- 32.66
- IV
- 69.2%
- B/E move
- 6.5%
65Δ
- Pseudo strike
- 26.90
- IV
- 75.7%
- B/E move
- 9.8%
- Pseudo strike
- 33.84
- IV
- 68.6%
- B/E move
- 5.2%
70Δ
- Pseudo strike
- 25.75
- IV
- 77.1%
- B/E move
- 8.1%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 24.44
- IV
- 80.4%
- B/E move
- 6.5%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 22.81
- IV
- 87.1%
- B/E move
- 5.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 77.36% | |
| 80.73% | |
| 70.15% | |
| 66.34% | |
| 67.30% | |
| 65.46% | |
| 74.21% | |
| 73.87% | |
| 71.70% | |
| 74.17% | |
| 74.84% | |
| 74.52% | |
| 75.08% | |
| 70.37% | |
| 72.81% | |
| 73.85% | |
| 75.90% | |
| 75.35% | |
| 69.58% | |
| 71.93% | |
| 76.85% | |
| 72.72% | |
| 74.41% | |
| 72.13% | |
| 74.86% | |
| 75.87% | |
| 87.94% | |
| 77.03% | |
| 76.50% | |
| 78.00% | |
| 79.20% | |
| 74.74% | |
| 80.72% | |
| 76.66% | |
| 87.04% | |
| 79.32% | |
| 80.15% | |
| 88.54% |
Diagnostics & Research
BLLN
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
More →CDNA
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
More →CRL
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell…
More →CSTL
Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests, particularly within the skin cancer sector,…
More →DGX
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains…
More →DHR
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional,…
More →